Education
About Us
Working with TipRanks
Follow Us
Renalytix Plc (RNLXY)
:RNLXY
RNLXY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.12 - $0.42
Previous CloseN/A
Volume36.17K
Average Volume (3M)42.42K
Market Cap
$33.18M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.10
Next Earnings
Nov 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding165,603,010
10 Day Avg. Volume32,653
30 Day Avg. Volume42,424
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Renalytix News
RNLXY FAQ
What was Renalytix Plc’s price range in the past 12 months?
Renalytix Plc lowest stock price was $0.12 and its highest was $0.42 in the past 12 months.
What is Renalytix Plc’s market cap?
Renalytix Plc’s market cap is $33.18M.
When is Renalytix Plc’s upcoming earnings report date?
Renalytix Plc’s upcoming earnings report date is Nov 04, 2025 which is in 88 days.
How were Renalytix Plc’s earnings last quarter?
Currently, no data Available
Is Renalytix Plc overvalued?
According to Wall Street analysts Renalytix Plc’s price is currently Overvalued.
Does Renalytix Plc pay dividends?
Renalytix Plc does not currently pay dividends.
What is Renalytix Plc’s EPS estimate?
Renalytix Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Renalytix Plc have?
Renalytix Plc has 165,603,010 shares outstanding.
What happened to Renalytix Plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Renalytix Plc?
Among the largest hedge funds holding Renalytix Plc’s share is Gilder Gagnon Howe & Co LLC.. It holds Renalytix Plc’s shares valued at 0.
Company Description
Renalytix Plc
Renalytix AI PLC is a developer of artificial intelligence-enabled clinical decision support solutions for kidney disease and costly chronic medical conditions globally. The company's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, patient stratification for drug clinical trials, and drug target discovery.
RNLXY Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlights significant achievements such as FDA approval, Medicare reimbursement, and strong revenue growth forecasts. However, challenges remain in scaling operations and international expansion.View all RNLXY earnings summariesTechnical Analysis
Rockwell Med
―
Rein Therapeutics
―
Lantern Pharma
―
Generation Bio
―
Connect Biopharma Holdings
―
Ownership Overview
21.14% Insiders
0.03% Mutual Funds
<0.01% Other Institutional Investors
78.85% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---